Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

What Is Cancer? Why and How Does It Develop? The Biology of Cancer

What Is Cancer? Why and How Does It Develop? The Biology of Cancer
In this article

When a Cell Breaks the Rules: A Plain-Language Journey Into Cancer Biology

Cancer is not a single disease. It is the shared name for hundreds of different diseases that arise when cells in our body lose the rules that govern how they grow and divide. Those rules are written in each cell's DNA, and as billions of cells divide every day, errors can creep into these instructions. The body's repair and surveillance systems correct almost all of them; cancer develops when a few critical errors pile up in the same cell over many years and that cell slips past the watch of the immune system. In this article, we explain in plain language the journey from a single cell to a disease that has spread, what causes cancer, and how this knowledge has been turned into today's treatments. We have previously covered 10 facts about the causes of cancer, the real causes of cancer and what metastasis means in separate articles.

20.6million: new cancer diagnoses worldwide in 2024
235,949estimated new cancer cases in Turkey in 2024
37 trillionapproximate number of cells in an adult human body
40%share of cancers in the US linked to modifiable risk factors
Quick Answer · Physician Summary
  • What is cancer? A group of diseases in which cells, starting from one of the body's own cells, divide out of control, invade the surrounding tissue and can spread to distant organs, as a result of changes that accumulate in that cell's DNA.
  • How does it develop? A single mutation is not enough. The switching on of "accelerator" genes that push the cell to grow (oncogenes), the failure of "brake" genes (tumour suppressor genes) and breakdowns in the DNA repair systems build up step by step, often over 10–20 years.
  • Why does it develop? Some mutations come from random copying errors when cells divide, some from environmental factors such as smoking, alcohol, excess weight, sunlight and infections, and a small share from an inherited predisposition passed down in families. Age is the strongest risk factor.
  • Why does it matter? About 40% of cancers are linked to preventable risk factors. Understanding cancer biology is the foundation of today's treatments, such as targeted drugs, immunotherapy and genetic testing.

Why does this topic matter?

More than 20 million people worldwide are diagnosed with cancer every year; roughly one in five people will face cancer at some point in their lives. In Turkey, about 236,000 new cancer cases were estimated for 2024. As populations age, these numbers are rising: the number of new cases worldwide is expected to reach 34 million by 2050 (the rise of cancer at a young age).

The 5 most common cancers worldwide (2024)

New cases, millions. GLOBOCAN 2024 estimates.

Lung
2.6M
Breast (female)
2.4M
Colorectal (large bowel)
2M
Prostate
1.5M
Stomach
1M

In 2024, an estimated 20.6 million new cancer cases occurred worldwide, with cancer-related loss of life estimated at 9.8 million people; as populations grow and age, the number of new cases is expected to reach 34 million by 2050.

The 5 most common cancers in Turkey (2024)

Number of new cases, both sexes. GLOBOCAN 2024 estimates for Turkey.

Lung
37,846
Breast
25,080
Colorectal (large bowel)
21,172
Prostate
18,749
Thyroid
18,291

A total of 235,949 new cancer cases; the most common is lung cancer in men (24%) and breast cancer in women (24.5%). Estimated cancer-related loss of life: 113,805.

For someone diagnosed with cancer, and for their loved ones, the first questions are often the same: "Why me?", "Did I cause this?", "Will my children get it?". The answers begin with understanding how cancer develops. Knowing the biology of cancer helps ease unnecessary guilt, recognise the risks that can be prevented, appreciate the value of screening and early diagnosis, and better understand the treatment options.

Is it a first? Milestones on the road to understanding cancer
Around 400 BC
"Karkinos"
Hippocrates described tumours whose blood vessels resembled a crab's legs with the word karkinos, meaning "crab"; the name "cancer" comes from this.
1775
The first environmental cause
Percivall Pott described a cancer linked to soot exposure in chimney sweeps; for the first time, an environmental factor was shown to be able to cause cancer.
1914
Chromosome abnormalities
Theodor Boveri proposed that cancer could arise from abnormalities in a cell's chromosomes.
1971
The two-hit hypothesis
Alfred Knudson showed that in retinoblastoma, an inherited eye tumour, both copies of a gene must be damaged for cancer to develop.
1976
Oncogenes are our own genes
Bishop and Varmus found that cancer-causing genes are altered versions of genes that are also present in our normal cells (Nobel Prize, 1989).
2000
The hallmarks of cancer
Hanahan and Weinberg described the core features shared by all cancers; this framework was expanded in 2011 and 2022.
2001–2003
Targeted drugs and the human genome
Imatinib, one of the first targeted cancer drugs, was approved, and the Human Genome Project was completed.
2018
Discovering the immune system's brakes
James Allison and Tasuku Honjo received the Nobel Prize for treating cancer by releasing the brakes of the immune system.

What is cancer, and why and how does it develop?

Cancer is a group of diseases that arise when the body's own cells, because of changes (mutations) that accumulate in their DNA, stop following the rules of growth and division, multiply out of control, invade the surrounding tissue and can spread to distant organs. These changes usually build up over years, through random errors during cell division, factors such as smoking, alcohol, excess weight, radiation and certain infections, and, less often, an inherited predisposition.

It all starts with a single cell

The body of an adult is made up of about 37 trillion cells, and about 330 billion cells are renewed every day. Skin, gut and blood cells are constantly being replaced, while nerve cells and heart muscle cells hardly divide at all. What keeps this order in place are the instructions written in the DNA inside each cell's nucleus: from them, a cell learns when to divide, when to stop, what to do when it is damaged, and how to remove itself when it grows old (the Human Genome Project).

Figure 1 · A normal cell and a cancer cell

A cancer cell is the same cell, now "breaking the rules"

Normal celldivides onlywhen neededstops when damaged,repairs itself orself-destructsdivides a limitednumber of timesstays in place Cancer celldivides evenwithout a signalkeeps dividingdespite damageescapes apoptosisdivides without limitspreads nearbyand far away The root of the difference: changes in DNAcancer is a disease that develops from our own cells
How to read it: A normal cell divides only when the body needs it to. If its DNA is damaged, it stops, repairs the damage, or, if repair is not possible, removes itself in an orderly, programmed way (apoptosis). After a certain number of divisions, it ages and stays in its own tissue. A cancer cell, by contrast, multiplies without any signal to divide, keeps dividing despite damage, escapes the self-destruct programme, can divide without limit, and spreads into nearby tissue and to distant organs.

Errors in DNA: the accelerator, the brakes and the repair crew

The DNA in every cell is damaged tens of thousands of times a day, and the cell's repair systems fix almost all of this damage. Permanent changes that escape repair and alter the cell's behaviour are called mutations. Most mutations are harmless; the ones that matter for cancer are those affecting three groups of genes that govern cell growth (cancer mutations).

Figure 2 · Three groups of genes involved in cancer

A simplified car analogy

Acceleratoroncogeneswhen overactive, thecell divides nonstope.g. KRAS, EGFR,HER2, MYC Brakestumour suppressorswhen both copies fail,the brakes come offe.g. TP53, RB1,APC, PTEN Repair crew: DNA repair geneswhen they fail, errors build up quicklye.g. BRCA1, BRCA2, mismatch repair (MMR) genes
How to read it: Oncogenes are the cell's accelerator. In their normal form (proto-oncogenes), they allow the cell to divide when needed; if a mutation jams them in the "on" position, the cell divides nonstop. Tumour suppressor genes are the brakes; usually both copies have to fail. DNA repair genes are the repair crew; when they break down, errors in other genes build up much faster. Cancer usually develops when faults in these three groups occur together.

Examples of accelerator genes are KRAS, EGFR and HER2, which today are among the targets of targeted drugs (what is HER2). The most important brake gene is TP53, also known as the "guardian of the genome": it is faulty in about half of all cancers. The best-known examples of repair-crew genes are BRCA1 and BRCA2, which are linked to hereditary breast and ovarian cancer. Changes can occur not only in the DNA sequence itself but also in the chemical tags that switch genes on and off (epigenetic changes) (epigenetics and biological age).

One mutation is not enough: cancer is a multistep process

Cancer usually develops not from a single mutation but from several critical changes that follow one another in the same cell lineage. In common solid tumours, the number of "driver" mutations steering the cancer is usually between 2 and 8; the dozens of other mutations found in a tumour are mostly "passengers". Each new driver mutation gives the cell a small advantage over its neighbours, and its descendants gradually multiply. This is why cancer is also described as a small process of evolution unfolding inside the body.

2–8driver mutations steering the cancer in common solid tumours
~140known driver genes that can trigger cancer
1billion: approximate number of cells in a tumour of one cubic centimetre
5–10%share of cancers due to an inherited predisposition

Figure 3 · How colorectal cancer develops, step by step

The best-studied example; the process usually takes 10–15 years

1 · Normal bowel celldivision and renewal are tightly controlled 2 · First critical mutation (e.g. APC)the brakes loosen; the cell divides a little more 3 · Small polyp (adenoma)benign; can be removed during colonoscopy 4 · New mutations (e.g. KRAS, TP53)the polyp grows, cells become disorganised (dysplasia) 5 · Cancercells settle into the bowel wall and advance 6 · Spread (metastasis)lymph nodes, liver, lungs
How to read it: In the large bowel, the first critical mutation usually occurs in a brake gene called APC, and the cells begin to divide a little more than they should. Over time, a small, benign polyp (adenoma) forms. As new mutations accumulate in the polyp in genes such as KRAS and TP53, the cells become increasingly disorganised, and eventually a cancer develops that grows into the bowel wall. As the cancer advances, it can spread to the lymph nodes and to distant organs such as the liver. Because polyps can be removed during colonoscopy along the way, screening can prevent cancer.

The length of this process is striking: a genetic analysis of pancreatic cancer estimated that about 15–20 years pass between the first critical mutation and the appearance of cells able to spread. Moreover, the normal tissues of healthy people also contain small groups of cells carrying cancer-related mutations, and very few of them ever turn into cancer. In other words, carrying a mutation is not the same as having cancer. This long process offers an important window of opportunity for screening and early diagnosis (screening with colonoscopy).

Figure 4 · Inherited and non-inherited cancer: two hits

Knudson's two-hit hypothesis

Inherited risk1st hit from birthpresent in every cella single new hitis enoughyounger age,more than one tumour Sporadic cancerboth hits mustoccur later in life,in the same cellolder age,usually a single tumour e.g. BRCA1/2, Lynch syndrome, retinoblastomaabout 5–10% of cancers involve an inherited predisposition
How to read it: For most brake genes, both copies must be damaged for cancer to develop. In people with an inherited predisposition, the first faulty copy is present from birth in every cell of the body, so a single new hit is enough; cancer appears at a younger age and sometimes in more than one organ. In non-inherited (sporadic) cancers, both hits must occur later in life in the same cell; this takes longer and usually happens at an older age.

About 5–10% of cancers involve an inherited predisposition. Cancer at a young age in the family, more than one cancer in the same person, or the same type of cancer appearing frequently in a family are important clues for genetic counselling (hereditary cancers, risk-reducing surgery in BRCA carriers). An inherited predisposition does not mean that cancer will definitely develop; it raises the risk and calls for closer follow-up.

Where do mutations come from?

Mutations have three main sources: random errors in copying DNA when cells divide, environmental and lifestyle factors, and predisposition inherited from our families. The relative share of these three sources varies greatly from one type of cancer to another.

Where do the mutations in cancer cells come from?

Percent. A model estimate of the sources of driver mutations across 32 cancer types (Tomasetti et al., Science 2017).

Source of mutations

66%
29%
DNA copying errors as cells divideEnvironment and lifestyle (smoking, radiation, infections, etc.)Inherited, passed down in families (5%)

These proportions refer to mutations, not to cancer cases. Even if most of the mutations in a cancer come from copying errors, an environmental factor can set off the cancer by adding a single critical mutation; this is why prevention still matters. The proportions vary greatly by cancer type: in lung cancer, the environmental share is much higher.

The large share of copying errors shows that some cancers can develop through "bad luck", without any risk factor at all. This is valuable in easing the "What did I do wrong?" guilt that many people diagnosed with cancer carry. On the other hand, it does not mean that cancer cannot be prevented: factors such as smoking, alcohol, excess weight and certain infections markedly increase the risk by adding one of the critical steps on the road to cancer (can cancer be prevented?).

The preventable share: how many cancers in the US are linked to which factor?

2019 data in adults aged 30 and over, percent (Islami et al., CA Cancer J Clin 2024).

All modifiable factors combined
40%
Smoking
19.3%
Excess weight
7.6%
Alcohol
5.4%

Other factors include the sun's ultraviolet rays, physical inactivity, diet and infections such as HPV. These factors were linked to 44% of cancer-related loss of life, with smoking accounting for 28.5%. Worldwide, about 13% of cancers are estimated to be caused by infections.

  • Smoking: Tobacco smoke contains more than 70 cancer-causing substances; besides the lungs, it causes cancer in many organs, including the mouth, larynx, oesophagus, bladder, pancreas and kidney (quitting smoking).
  • Alcohol: In the body, it is converted into acetaldehyde, which damages DNA directly; there is no safe lower limit (how alcohol damages DNA).
  • Excess weight and physical inactivity: Through hormones, insulin and inflammation, fat tissue raises the risk of at least 13 types of cancer (obesity and cancer).
  • Infections: HPV (cervix, head and neck), hepatitis B and C (liver) and Helicobacter pylori (stomach) account for about 13% of cancers worldwide; these can be prevented with vaccination and treatment (20 years of the HPV vaccine, Helicobacter pylori and stomach cancer).
  • Age: The strongest risk factor. Because mutations accumulate over time and both repair and immune surveillance weaken with age, the vast majority of cancers occur after the age of 50 (why cancer is more common in men).

What all cancers have in common

Although hundreds of different types of cancer arise in different organs and through different mutations, the abilities that cancer cells acquire are remarkably similar. In 2000, Douglas Hanahan and Robert Weinberg described these shared abilities as the "hallmarks of cancer". The list was expanded with new knowledge in 2011 and 2022 and today includes 14 items.

Figure 5 · The 14 hallmarks of cancer

The abilities cancer cells acquire, and the conditions that make them possible

1 · Making its owngrowth signals 2 · Ignoring thegrowth brakes 3 · Escapingapoptosis 4 · Endless divisiontelomerase 5 · Building newblood vessels 6 · Invasion andmetastasis 7 · Reprogrammingenergy metabolism 8 · Evading theimmune system 9 · Genome instabilityenabling condition 10 · Tumour-promotinginflammation 11 · Changingcell identity 12 · Epigenetic changewithout mutation 13 · Microbiomebacterial communities 14 · Aged(senescent) cells Hanahan and Weinberg: hallmarks of cancerwhite boxes 2000 · coloured outlines 2011shaded boxes 2022
How to read it: The first six hallmarks (2000) are the cancer cell's ability to produce its own growth signals, ignore the brakes, escape programmed cell death (apoptosis), divide without limit with the help of the enzyme telomerase, build new blood vessels, and invade tissue and spread. In 2011, reprogrammed energy metabolism and escape from the immune system were added, while genome instability and tumour-promoting inflammation were defined as conditions that make it easier to acquire these abilities. In 2022, the ability of cells to change their identity, changes in gene settings without any change in the DNA sequence (epigenetics), bacterial communities (the microbiome) and aged cells joined the list.

One of these hallmarks shows up directly in everyday practice: most cancer cells use sugar in a fast, "wasteful" way even when oxygen is available (the Warburg effect). This is why radioactive sugar (FDG) builds up intensely in tumours on a PET-CT scan (what FDG uptake means). However, this does not mean that "eating sugar feeds cancer": blood sugar is tightly regulated by the body, and cutting out sugar does not stop a tumour from growing.

A tumour is never alone: the microenvironment

A tumour is not made up of cancer cells alone. Cancer cells steer the normal cells around them to work in their favour, creating a complex ecosystem that functions much like an organ. Nor are the cancer cells within a tumour identical: subgroups carrying different mutations live side by side. This diversity (heterogeneity) means that while the cells that respond to a treatment disappear, the resistant ones can multiply, and resistance can develop over time (how cancer cells develop resistance).

Figure 6 · The tumour microenvironment

Cancer cells and the normal cells that support them

Cancer cellsat the heart of the tumour, in diverse subgroups Fibroblastsprovide scaffoldingand growth factors Immune cellsmay recognise thetumour or be held back Blood vesselscarry oxygenand nutrients Extracellular matrixa route for spread,a barrier to drugs The tumour behaves like an "organ"treatments can also targetthe cancer cell's surroundings
How to read it: Alongside the cancer cells, a tumour contains fibroblasts that provide scaffolding and growth factors, immune cells that can recognise the tumour but are often held in check, blood vessels that carry oxygen and nutrients, and the material between cells (extracellular matrix). This ecosystem influences how the tumour grows, how it spreads and how it responds to treatment. That is why some treatments target not the cancer cell itself but the blood vessels or the immune cells.

The bacterial communities in the gut and within tumours (the microbiome) are also part of this ecosystem; some bacteria can contribute to cancer through inflammation and DNA damage, while others can influence the response to immunotherapy (the microbiome and colorectal cancer).

The immune system and cancer

The immune system keeps constant watch against cancer, recognising abnormal cells and clearing them away. The fact that some cancers are more common in people whose immune system is suppressed (for example, after an organ transplant) is evidence of this. Cancer can progress only once it manages to slip past this surveillance (immune tolerance).

Figure 7 · Three phases between the immune system and cancer

The concept of "immunoediting"

1 · Eliminationimmune cells recognise and clear abnormal cells 2 · Equilibriumremaining cells are held in check, quiet for years 3 · Escapethe tumour uses "brake" molecules (such as PD-L1),becomes invisible or suppresses the immune system Immunotherapyreleases the brakes and reactivates the immune system
How to read it: In the first phase, immune cells recognise and remove most abnormal cells. In the second phase, the remaining cells can stay quiet for a long time under the control of the immune system. In the third phase, some cells manage to escape, by using molecules that put the brakes on the immune system (such as PD-L1), by making themselves invisible or by suppressing their surroundings, and the tumour grows. Immunotherapy drugs release these brakes and reactivate the immune system.

Spread: metastasis

Most cancer-related loss of life is caused not by the original tumour but by spread to distant organs (metastasis). Metastasis requires a cancer cell to clear a series of difficult steps, which makes it a very "inefficient" process: fewer than one in ten thousand cancer cells that enter the bloodstream can form a new tumour (does a biopsy spread cancer?).

Figure 8 · The steps of metastasis

At each step, the vast majority of cells fall away

1 · Local invasioncells loosen their bonds and enter nearby tissue 2 · Entering a blood or lymph vessel 3 · Surviving in the circulationdespite immune cells and the pressure of blood flow 4 · Leaving the vessel in a distant organ 5 · Micrometastasis and dormancycells can stay quiet for years 6 · Colonisation: a new tumour formsthe hardest step; very few cells succeed
How to read it: Cancer cells first loosen their connections and invade the surrounding tissue, then enter blood or lymphatic vessels. Those that survive in the circulation, despite immune cells and the pressure of blood flow, leave the vessels in a distant organ. There they form tiny clusters (micrometastases) and can sometimes remain dormant for years. The hardest step is for these cells to adapt to their new environment and form a growing tumour. Late recurrences seen 10–20 years later in breast cancer are explained by this dormancy.
<0.01%share of cancer cells entering the bloodstream that can form a new tumour
15–20years: estimated time in pancreatic cancer from the first critical mutation to the ability to spread
330billion: approximate number of cells renewed in our body every day
14hallmarks of cancer and the conditions that enable them (2022)

Each cancer tends to spread to particular organs: for example, breast and prostate cancer often spread to bone, and colorectal cancer to the liver. This depends both on the direction of blood flow and on how well the cancer cell "fits" the new tissue; the "seed and soil" analogy proposed in the 19th century still holds true today.

Types of cancer: by the cell of origin

Main group Tissue of origin Examples
Carcinoma Cells that line organs and surfaces (epithelium) Lung, breast, colorectal, prostate, stomach; about 80–90% of all cancers
Sarcoma Bone, muscle, fat and connective tissue Osteosarcoma, liposarcoma
Leukaemia Blood-forming cells in the bone marrow Acute and chronic leukaemias
Lymphoma and myeloma Cells of the immune system Hodgkin and non-Hodgkin lymphoma, multiple myeloma
Brain and nervous system tumours Supporting cells of the brain and spinal cord Glioma, glioblastoma
Others Germ cells, pigment cells, hormone-producing cells Testicular tumours, melanoma, neuroendocrine tumours

Even cancers of the same organ can behave very differently depending on their cell type and molecular features; this is why pathology and, when needed, molecular testing are decisive in diagnosis.

From biology to treatment

Most of the progress in cancer treatment over the past 25 years has grown out of understanding the biology described above. While classic chemotherapy and radiotherapy target rapidly dividing cells, today we can use treatments that target a tumour's own particular weak spots. Tests that examine the genetic makeup of a tumour are becoming increasingly important in deciding which patient will benefit from which treatment (next-generation sequencing, what the mutations in a genetic test report mean).

Figure 9 · From the hallmarks of cancer to treatments

A simplified matching

Rapid divisionchemotherapy,radiotherapy,CDK4/6 inhibitors Growth signalstargeted drugs:EGFR, HER2, ALK,BRAF inhibitors Hormone dependencehormone therapy(breast, prostate) New blood vesselsdrugs that blockvessel formation Immune escapeimmunotherapy,CAR T, vaccines DNA repair defectsPARP inhibitors,immunotherapy (MSI) The right target: pathology + molecular testseven cancers of the same organ differ between patients
How to read it: Rapid division is targeted with chemotherapy, radiotherapy and CDK4/6 inhibitors; growth signals with targeted drugs aimed at targets such as EGFR, HER2, ALK and BRAF; hormone dependence with hormone therapy; new blood vessel formation with drugs that block it; immune escape with immunotherapy, CAR T cells and vaccines; and DNA repair defects with PARP inhibitors and, in some cases, immunotherapy. Choosing the right treatment first requires determining the tumour's pathological and molecular features.

Treatments that activate the immune system (immunotherapies and cancer vaccines) and new technologies such as gene editing (CRISPR) are the latest examples of cancer biology being turned into treatment.

Common misconceptions

Misconception The scientific facts
Cancer is contagious. Cancer does not pass from person to person. Some viruses that can cause cancer (HPV, hepatitis B and C) can be transmitted; these can be prevented with vaccination and protection.
Sugar feeds cancer, and cutting out sugar stops it. All cells use sugar, and blood sugar is regulated by the body. Cutting out sugar does not shrink a tumour, although excess weight raises the risk indirectly.
A biopsy or surgery spreads cancer. A biopsy performed with the proper technique does not spread cancer; it is essential for the correct diagnosis and treatment.
Cancer is always inherited. Only 5–10% of cancers involve a strong inherited predisposition; most develop from mutations that accumulate over a lifetime.
Stress alone causes cancer. Stress has not been shown to cause cancer directly; however, it can affect risk indirectly, through smoking, alcohol and physical inactivity.
Herbal products and "natural" methods cure cancer. Methods with no proven effectiveness can delay effective treatment and lead to drug interactions (the risks of alternative products).
The situation in Turkey

According to GLOBOCAN 2024 estimates, about 236,000 people in Turkey are diagnosed with cancer each year. The most common cancers are lung, prostate and colorectal cancer in men, and breast, thyroid and colorectal cancer in women. The fact that lung cancer makes up about a quarter of all cancers in men shows how heavily smoking weighs on the cancer burden in our country. At the Ministry of Health's Cancer Early Diagnosis, Screening and Training Centres (KETEM), Turkey's free cancer screening centres, screening for breast, cervical and colorectal cancer is offered free of charge. We have covered preventable cancers in our article on the 8 most preventable cancers.

Protecting yourself

  • Do not smoke: It is the single largest preventable cause of cancer; quitting lowers the risk at any age.
  • Limit alcohol, or avoid it altogether: When it comes to cancer, there is no safe lower limit.
  • Maintain a healthy weight and stay active: Regular physical activity and a diet rich in vegetables, fruit and whole grains lower the risk of many cancers.
  • Vaccination and treating infections: HPV and hepatitis B vaccines, and treatment for hepatitis C and Helicobacter pylori, help prevent cancer.
  • Protect yourself from the sun: Avoid the sun, especially around midday, and do not use sunbeds.
  • Keep up with screening: Breast, cervical and colorectal cancer screening, and lung cancer screening for those who qualify, can catch cancer early or even before it forms (lung cancer screening).
  • Know your family history: If there is cancer at a young age, or many cases of cancer, in your family, ask for genetic counselling.

Frequently asked questions

What is cancer?
Cancer is a group of diseases in which the body's own cells, because of changes that accumulate in their DNA, divide out of control, invade the surrounding tissue and can spread to distant organs. It is not a single disease: there are hundreds of different types, depending on the organ of origin, the cell type and molecular features.
Why does cancer develop?
Cancer develops when mutations accumulate in the genes that control cell growth. Some of these mutations come from random errors during cell division, some from factors such as smoking, alcohol, excess weight, sunlight and certain infections, and about 5–10% from an inherited predisposition. Age is the strongest risk factor.
How long does it take for cancer to develop?
Most cancers develop over years, even decades, from the first critical mutation to diagnosis. For example, colorectal cancer usually develops from a polyp over 10–15 years, and in pancreatic cancer it has been estimated that 15–20 years pass between the first mutation and the ability to spread. This long period offers an opportunity for screening and early diagnosis.
Can cancer be prevented?
A substantial share of cancers can be prevented. According to US data, about 40% of cancers are linked to modifiable factors such as smoking, excess weight, alcohol, physical inactivity, sunlight and infections. Vaccines, screening and healthy lifestyle habits markedly reduce the risk; however, some cancers can develop even without any risk factor.

Glossary

Mutation
A permanent change in the DNA sequence.
Oncogene
A gene that, when mutated, pushes the cell to divide continuously; the cell's "accelerator".
Tumour suppressor gene
A gene that puts the brakes on cell division; when it fails, the brakes come off. Example: TP53.
Driver mutation
A mutation that plays a direct role in the development of cancer; the others are called "passenger" mutations.
Apoptosis
Programmed cell death: the orderly self-destruction of a damaged or unneeded cell.
Telomere
The protective cap at the ends of chromosomes that shortens with each division; cancer cells get around this limit with the enzyme telomerase.
Epigenetics
Chemical tags that switch genes on and off without changing the DNA sequence.
Tumour microenvironment
The normal cells, blood vessels and extracellular material surrounding cancer cells.
Metastasis
The spread of cancer cells from their organ of origin to distant organs.
Dysplasia
A precancerous change in which cells have become disorganised but are not yet cancer.

DROZDOGAN Academy Commentary

Cancer is not an outsider that enters our body from somewhere else; it is our own cells losing their rules through errors that build up over the years. This perspective eases both fear and guilt, while also showing the value of prevention and early diagnosis.

⚡ Why it matters

Understanding cancer biology explains why some cancers can be prevented, why screening works, why two patients with the "same" cancer are treated differently, and why resistance to treatment sometimes develops.

✅ What we know today

The genetic and cellular foundations of cancer have been largely uncovered. This knowledge has been turned into many treatments and diagnostic methods, such as targeted drugs, immunotherapy, PARP inhibitors and tracking tumour DNA in the blood.

⚠️ What we do not yet know

Why dormant cancer cells wake up years later, how to control the diversity within a tumour, and how to prevent metastasis remain among the biggest questions.

🩺 In practice

When we explain to our patients "why" their cancer developed, we use language that does not assign blame; at the same time, we emphasise that changes such as quitting smoking, managing weight and staying active still bring benefits after diagnosis. In planning treatment, we assess the tumour's pathological and molecular features together.

❓ Open questions

Will it become possible to detect cancers with a simple blood test long before they cause symptoms? Will we be able to predict which normal cells carrying mutations will turn into cancer? Can we train the immune system to prevent cancer?

Bottom line: Cancer is a long process that begins when a cell loses its rules. Every step of this process is a new opportunity for prevention, early diagnosis and treatment.

Transparency note
  • This article was prepared in October 2026.
  • Statistics are taken from GLOBOCAN 2024 estimates (International Agency for Research on Cancer), and the preventable share from a 2024 analysis of US data; this proportion may differ for Turkey.
  • The proportions for the sources of mutations (66%, 29%, 5%) are estimates from a mathematical model and are debated in the scientific community; they show the sources of mutations, not of cancer cases.
  • Numerical values (number of cells, number of driver mutations, efficiency of metastasis, timescale in pancreatic cancer) are approximate and may be reported differently in different studies.
  • This article is for general information only and is not personal medical advice. The diagrams are simplified. The Academy commentary is our own.

References

  1. Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov 2022;12:31-46. doi:10.1158/2159-8290.CD-21-1059
  2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-674. doi:10.1016/j.cell.2011.02.013
  3. Vogelstein B, Papadopoulos N, Velculescu VE, et al. Cancer genome landscapes. Science 2013;339:1546-1558. doi:10.1126/science.1235122
  4. Tomasetti C, Li L, Vogelstein B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science 2017;355:1330-1334. doi:10.1126/science.aaf9011
  5. Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010;467:1114-1117. doi:10.1038/nature09515
  6. Islami F, Marlow EC, Thomson B, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019. CA Cancer J Clin 2024. cancer.org
  7. GLOBOCAN 2024 Turkey fact sheet. International Agency for Research on Cancer (IARC). gco.iarc.who.int
  8. IARC releases GLOBOCAN 2024. UICC, July 2026. uicc.org
  9. American Cancer Society reports latest global cancer statistics. The ASCO Post, July 2026. ascopost.com
  10. de Martel C, Georges D, Bray F, et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health 2020;8:e180-e190. doi:10.1016/S2214-109X(19)30488-7
  11. Sender R, Milo R. The distribution of cellular turnover in the human body. Nat Med 2021;27:45-48. doi:10.1038/s41591-020-01182-9
DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

What Is Cancer? Why and How Does It Develop? The Biology of Cancer

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy